Newsletter | December 16, 2021

12.16.21 -- BioProcess Online Top 10 Of 2021


As the year winds down, here's a reflective look at the most-read content published at Bioprocess Online in 2021. The list is heavy with regulatory, vaccine, COVID-19, manufacturing capacity, and supply chain stories in the wake of a year marked by great challenge — and even greater growth opportunity — for biopharma. 


We're grateful for the incredible contributing experts who share their insight with our audience. We're also thankful for the support of an industry eager to help biopharma companies overcome their process and manufacturing challenges as they work in earnest to meet patient needs. 


Soak up the knowledge, and happy holidays from your friends at Bioprocess Online


Matthew Pillar

Bioprocess Online & The Business of Biotech Podcast


Top 10 From The Editor Columns
Top 10 Guest Columns
  1. Outlook: Biotech In 2021 And Beyond
  2. An Analysis Of The Gene Therapy Viral Vector Landscape
  3. 10 Most-Cited MHRA GMP Inspection Deficiencies By Annex/Chapter
  4. FDA FY2020 Drug Inspection Observations And Trends
  5. Bioprocessing Year In Review: 11 Key Trends Accelerated By COVID-19
Top 10 Industry Insights
  1. Five Dangers Of An Insecure API Supply Chain
  2. Vaccine Bioprocessing Handbook
Top 10 Products And Services